Michael S. von Bergwelt‐Baildon

Author

Also Known As

Carl H June, M S VON BERGWELT-BAILDON, M S Von Bergwelt-Baildon, M S von Bergwelt-Baildon, M. S. Von Bergwelt‐Baildon, M.S. von Bergwelt-Baildon, Michael Bergwelt-Baildon, Michael Bergwelt‐Baildon, Michael S von Bergwelt-Baildon, Michael S. Von Bergwelt-Baildon

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

University of Cologne University Hospital Cologne Harvard University Brigham and Women's Hospital Dana-Farber Cancer Institute

About

Michael S. von Bergwelt‐Baildon is an author at University of Cologne specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	299
2	Cell Biology	6	6	191
3	Allergy	2	2	52
4	Blood Transplantation	1	1	11
5	Cellular Physiology	1	1	22

Michael S. von Bergwelt‐Baildon

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition Michael S. von Bergwelt‐Baildon, Alexey Popov, Tomo Šarić, Blood	2006	240
Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application Michael S. von Bergwelt‐Baildon, Robert H. Vonderheide, Britta Maecker, Blood	2002	190
Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity Naoto Hirano, Marcus O. Butler, Zhinan Xia, Blood	2005	174
Characterization of tumor-associated B-cell subsets in patients with colorectal cancer Alexander Shimabukuro‐Vornhagen, Hans Schlößer, Luise Gryschok, Oncotarget	2014	130
Autoantibodies frequently detected in patients with aplastic anemia Naoto Hirano, Marcus O. Butler, Michael S. von Bergwelt‐Baildon, Blood	2003	112
The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells Britta Maecker, David H. Sherr, Robert H. Vonderheide, Blood	2003	83
Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals. Robert H. Vonderheide, Joachim L. Schultze, Karen S. Anderson, PubMed Universal Tumor AntigenRadiation OncologyTumor-bearing PatientsHealthy IndividualsCancer Immunosurveillance	2001	80
O‐Linked glycans control glycoprotein processing by antigen‐presenting cells: a biochemical approach to the molecular aspects of MUC1 processing by dendritic cells Franz‐Georg Hanisch, Tilo Schwientek, Michael S. von Bergwelt‐Baildon, European Journal of Immunology	2003	66
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours Martin R. Weihrauch, Heike Richly, Michael S. von Bergwelt‐Baildon, European Journal of Cancer Toll-like Receptor 9Agonist Mgn1703MedicineMetronomic TherapyImmunology	2014	64
B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies Hans Schlößer, Martin Thelen, Axel Lechner, OncoImmunology	2018	63

Page 1